Posts

We understand that as a medical professional your life can be rather hectic. We want to learn but we want to learn fast! Which is why we have launched our brand new online training academy. This is a great way to further your knowledge within the Aesthetic Industry as well as providing a resource for you to refer back to 24/7, ensuring you feel confident in your practice!

To kick start our online academy we have the following two courses available:

1. Introduction to Botulinum Toxin Type A

The first of our online courses is an Introduction to Botulinum Toxin Type A. A great course if you are starting off in the Aesthetic Industry to further your knowledge of Botulinum Toxin Type A.  Although an excellent introductory course, it’s also beneficial if you are wanting to refresh your knowledge in this area.

The course itself takes around 30 minutes to complete from start to finish but can be done through various sittings. At the end of the course there is a short online test which on successful completion will award you a certificate.

Within the course there are 10 pods including: 

  • Pharmacology
  • Reconstitution & preparation
  • Dosages
  • Contraindications
  • Patient information and aftercare sheets
  • Games & quizzes to test your knowledge

2. Introduction to Dermal Fillers

The second of our online courses is an Introduction to Dermal Fillers. A topic that naturally goes hand in hand with our botulinum toxin training above.

The course is laid out in a similar format to the Introduction to Botulinum Toxin Type A module with 10 pods to navigate through ending with a multiple choice test to assess your knowledge.

This module will teach you how the dermal fillers work, where it can be used and the relevant contraindications to it’s use.

The 10 pods include the following:

  • Outline of the different types of fillers & patient selection
  • Pharmacology of dermal fillers & Hyaluronidase
  • Contraindications to dermal fillers & Hyaluronidase
  • Patient information & aftercare sheets
  • Games & quizzes to test your knowledge

Online Learning with Cosmetic Courses

We have combined a variety of learning elements to ensure this course is practical and beneficial for all users.

On successful completion of the courses, you are awarded a certificate and have the option to go back and look through the pods at any time.

There’s no middle man to our online courses either, you can sign in at the top of our website and any problems or queries come directly to us. So we can help you take your next steps within the aesthetic industry!

“I found the online course extremely beneficial for my learning and development in this fast paced industry. The layout and design were pleasing to the eye with great content to match. I especially love how you can refer back to the pods at anytime, even after you have completed the course!”

Want to know more about online training and enroll?

Speak to a member of our friendly team now, they will set up your account and get the ball rolling for your successful completion of our online courses.  Each of our online courses are £50 + VAT but if you would like to purchase both modules together this is currently on offer for £85 + VAT for the two modules.

Visit our brand new online learning page to find out more about the courses on offer to support your aesthetic learning! 

To take advantage of this offer and purchase your online course please call or email us on: 01844 390110 / [email protected]

 

First Migraines, now Asthma…what else can Botox Treat?

We are not skeptics about the wonders of Botox, or Botulinum Toxin Type A.  We are, of course, already familiar with its potential for smoothing fine lines and wrinkles, treating excess sweating (hyperhidrosis) and even of its medicinal uses for an array of good: from Essential Tremor to Multiple Sclerosis and Cerebal Palsy (almost any condition involving involuntary muscle movement!).  More recently, those in the Medical Aesthetics industry have heard of the potential to treat their patients with Botox injections for Migraine. And now, the most recent development launched in Australia on Tuesday, comes testing of Botox as an Asthma alleviant.

Monash University tests Botox for Vocal Exhaustion
The research, conducted at Melbourne’s Monash University, involves particularly severe asthma cases….and Botox injections directly to the voicebox!

The focus is ‘vocal exhaustion’: as the Telegraph has reported, ‘half of people with asthma also have voicebox spasms that can make it difficult to exercise or perform other normal activities’.  The theory is that using Botulinum Toxin Type A to work its paralysing magic on the voicebox will stop the spasms, allowing severe asthma sufferers to resume normal standards of breathing and activity.

Is Botox to the Throat really Safe
Botox is already used for other vocal chord disorders (like spasmodic dysphonia) so there is definitely logic behind this line of thinking and it could well work…if patients can be persuaded to have shots of paralytic toxin directly to their throats! The trials (lasting a year and initially conducted on 60 patients – 30 real, 30 placebo) are only based in Australia for now and the USA and UK are likely to take a little more persuading before theydecide to go ahead with similar research.  For now, these countries are probably happy to sit back and watch with interest as director of respiratory medicine, Phil Bardin, and his team conduct the pioneering study: particularly as they are currently only “reasonably reassured that it’s safe”. Temporary quietness of the voice, however, is the only side-effect that they claim to be expecting.

One thing is for sure: continued research like this does show the credibility of Botulinum Toxin as a career path for Medical Professionals….this is not just a “Beauty” sector and there is a great deal of good, potential for pioneering work and health treatments which can be performed once you choose to train in Botox techniques.

The Agence Francaise de Securite Sanitaire des Produits de Sante (AFSSAPS) first approved Allergan, Inc.’s Botox® product, botulinum toxin type A, for treatment of glabellar lines in 2003. Allergan, Inc. markets its Botox® product in France under the product name Vistabel®, which was licenced for the same use in the U.K. in March 2006. At the time, France became the nineteenth country to licence Allergan, Inc.’s Botox® product.

Glabellar lines are the vertical frown lines between the eyes, generated by emotions of stress and anger. Over time, the lines can become permanent, giving a perpetual appearance of stress or anger. Botox® / Vistabel® relaxes the muscles causing frown lines, smoothing the skin between the eyebrows. It works by temporarily preventing facial nerve endings, which receive a signal from the brain to display a particular emotion, from releasing acetycholine. The temporary failed release lasts several months, preventing the nerve endings from controlling the facial muscles. The procedure is quick and easy, and minimally invasive, requiring only a few small injections into the skin. Results are nearly instantaneous.

The product has been proven safe and effective in clinical trials. More than eighty per cent of patients involved in the clinical studies saw the maximum effect from the drug. The side effects included headache, respiratory infection, flu syndrome, temporary eyelid droop and nausea. Patients who experience any hypersensitivity to specific ingredients in the product should not receive Botox® / Vistabel® treatments. The product is available by prescription only, and Allergan, Inc. does recommend that Botox® / Vistabel® treatments be administered by a qualified and experienced physician who specializes in cosmetic treatments, and it should be administered in an appropriate medical facility.

Allergan manufactures its Botox® / Vistabel® product, generically called Clostridium botulinum type – A neurotoxin complex, from a naturally occurring protein called purified type – A neurotoxin, which is produced by the bacteria Clostridium botulinum. The drug is now approved in more than seventy countries for a variety of uses beyond treatment of glabellar lines. The United Kingdom in particular has approved the product for treatment of blepharospasm, hemifacial spasm, cervical dystonia, severe hyperhidrosis of the axillae, dynamic equines foot deformity in children with cerebral palsy, and for wrist and hand disability caused by adult stroke.

Allergan, Inc. is headquartered in Irvine, California. The company has successfully marketed its Botox® and Vistabel® products worldwide, advancing its corporate mission of improving patients’ lives.

The allure of youth is potent, especially to women who feel pressured society to look a certain way. When medical procedures that could improve the appearance of frown lines between brows emerged, women all over the world clamored to be the first line. Shortly, these women became frequent customers fueling a multi-billion pound industry.

Botox Cosmetic (Botulinum Toxin Type A) contains the same toxin that causes food poisoning. Used in a clinical setting in an injectable, sterile form, the Botox blocks the release of acetylcholine, which nerve cells use to signal muscle contraction. A doctor can use the Botox to interfere selectively with the muscles’ ability to contract. The process smoothes the frown lines and, in many cases, makes them invisible within a week. This result has made Botox injections the most prevalent cosmetic procedure in the world including breast enhancement surgery.

In the US, the FDA initially approved Botox in 1989 as a treatment for misaligned eyes (strabismus) and uncontrollable blinking (blepharospasm). In 2000, this approval widened to include severe neck and shoulder contractions (cervical dystonia). It was during the treatment of strabismus and blepharospasm that doctors realized it was softening the glabellar lines between eyebrows. This vertical frown between the eyebrows is what makes people look angry, displeased or tired.

Additional clinical studies commenced and by 2002, the US’s FDA was satisfied with the evidence of Botox’s safety and ability to reduce frown lines for up to 120 days. However, the FDA approves products but does not regulate their use. This flexibility has led to a wide range of procedures in the US of which there have been no clinical evaluations and certainly no explicit demonstration of safety.

Another factor driving the popularity of Botox among women is the social aspect that has become a part of the drug’s marketing. Volume discounts are available for many types of medicines including Botox. Therefore, it has become a prevalent practice for doctors to purchase Botox in bulk and then hold gatherings for their patients. Women gather at these Botox parties for the injection at a discount, food and drink, and camaraderie. This phenomenon began in the US but has since emerged everywhere where Botox injections are legal.

Regulatory agencies around the world, such as the MHRA and FDA, have indicated increased concern over the potential for Botox abuse. The social aspect of the drug has led to unqualified technicians performing the procedure in home-based offices, retail venues, gyms, and salons. In these situations, the patient runs serious risks of inappropriate dosages and unsanitary conditions. However, this does not dissuade millions of women from repeating the process continuously, chasing that ever-elusive fountain of youth.